Patents by Inventor Steen B. Haugaard

Steen B. Haugaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of selecting and treating subjects with low-grade inflammation and metabolic disorders
    Patent number: 9645157
    Abstract: The invention concerns a marker for low-grade inflammation and metabolic syndrome (MS) and MS-related diseases and/or low-grade inflammation-related diseases such as cardiovascular disease, ischemic heart disease and type 2 diabetes. More particularly it concerns the measurement of the concentration of soluble urokinase plasminogen activator receptor (suPAR) in human biological fluids (sputum, cystic fluid, ascites, serum, plasma, urine) as a tool of diagnosing and/or prognosticating low-grade inflammation and metabolic syndrome and the risk of development of the related diseases such as cancer, cardiovascular disease, ischemic heart disease and type 2 diabetes.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: May 9, 2017
    Assignee: Hvidovre Hospital
    Inventors: Jesper Eugen-Olsen, Steen B. Haugaard, Ove Andersen
  • METHOD AND TOOL FOR PREDICTING CANCER AND OTHER DISEASES
    Publication number: 20140370527
    Abstract: The invention concerns a marker for low-grade inflammation and metabolic syndrome (MS) and MS-related diseases and/or low-grade inflammation-related diseases such as cardiovascular disease, ischemic heart disease and type 2 diabetes. More particularly it concerns the measurement of the concentration of soluble urokinase plasminogen activator receptor (suPAR) in human biological fluids (sputum, cystic fluid, ascites, serum, plasma, urine) as a tool of diagnosing and/or prognosticating low-grade inflammation and metabolic syndrome and the risk of development of the related diseases such as cancer, cardiovascular disease, ischemic heart disease and type 2 diabetes.
    Type: Application
    Filed: June 23, 2014
    Publication date: December 18, 2014
    Inventors: Jesper Eugen-Olsen, Steen B. Haugaard, Ove Andersen
  • Method for predicting cancer and other diseases
    Patent number: 8815519
    Abstract: The invention concerns a marker for low-grade inflammation and metabolic syndrome (MS) and MS-related diseases and/or low-grade inflammation-related diseases such as cardiovasculardisease, ischemic heart disease and type 2 diabetes. More particularly it concerns the measurement of the concentration of soluble urokinase plasminogen activator receptor (suPAR) in human biological fluids (sputum, cystic fluid, ascites, serum, plasma, urine) as a tool of diagnosing and/or prognosticating low-grade inflammation and metabolic syndrome and the risk of development of the related diseases such as cancer, cardiovascular disease, ischemic heart disease and type 2 diabetes.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: August 26, 2014
    Assignee: Hvidovre Hospital
    Inventors: Jesper Eugen-Olsen, Steen B. Haugaard, Ove Andersen
  • METHOD AND TOOL FOR PREDICTING CANCER AND OTHER DISEASES
    Publication number: 20100098705
    Abstract: The invention concerns a marker for low-grade inflammation and metabolic syndrome (MS) and MS-related diseases and/or low-grade inflammation-related diseases such as cardiovasculardisease, ischemic heart disease and type 2 diabetes. More particularly it concerns the measurement of the concentration of soluble urokinase plasminogen activator receptor (suPAR) in human biological fluids (sputum, cystic fluid, ascites, serum, plasma, urine) as a tool of diagnosing and/or prognosticating low-grade inflammation and metabolic syndrome and the risk of development of the related diseases such as cancer, cardiovascular disease, ischemic heart disease and type 2 diabetes.
    Type: Application
    Filed: December 12, 2007
    Publication date: April 22, 2010
    Inventors: Jesper Eugen-Olsen, Steen B. Haugaard, Ove Andersen